These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27894115)

  • 1. Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.
    Macdougall IC; Vernon K
    Am J Nephrol; 2017; 45(1):60-62. PubMed ID: 27894115
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.
    Rampton D; Folkersen J; Fishbane S; Hedenus M; Howaldt S; Locatelli F; Patni S; Szebeni J; Weiss G
    Haematologica; 2014 Nov; 99(11):1671-6. PubMed ID: 25420283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    Hempel JC; Poppelaars F; Gaya da Costa M; Franssen CF; de Vlaam TP; Daha MR; Berger SP; Seelen MA; Gaillard CA
    Am J Nephrol; 2017; 45(1):49-59. PubMed ID: 27889746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
    Szebeni J
    Drug Discov Today; 2018 Mar; 23(3):487-492. PubMed ID: 29326077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
    Szebeni J; Storm G
    Biochem Biophys Res Commun; 2015 Dec; 468(3):490-7. PubMed ID: 26182876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
    Szebeni J
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):567-606. PubMed ID: 11789676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
    Szebeni J; Bedőcs P; Csukás D; Rosivall L; Bünger R; Urbanics R
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1706-16. PubMed ID: 22820530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation.
    Verhoef JJF; de Groot AM; van Moorsel M; Ritsema J; Beztsinna N; Maas C; Schellekens H
    Biomaterials; 2017 Mar; 119():68-77. PubMed ID: 28002754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
    Szebeni J; Alving CR; Rosivall L; Bünger R; Baranyi L; Bedöcs P; Tóth M; Barenholz Y
    J Liposome Res; 2007; 17(2):107-17. PubMed ID: 17613700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
    Szebeni J; Muggia F; Gabizon A; Barenholz Y
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines.
    Gomollón F; Chowers Y; Danese S; Dignass A; Haagen Nielsen O; Lakatos PL; Lees CW; Lindgren S; Lukas M; Mantzaris GJ; Michetti P; Moum B; Peyrin-Biroulet L; Toruner M; van der Woude J; Weiss G; Stoevelaar H; Reinisch W
    Aliment Pharmacol Ther; 2014 Apr; 39(7):743-4. PubMed ID: 24588280
    [No Abstract]   [Full Text] [Related]  

  • 13. The complex world of adverse reactions.
    AJR Am J Roentgenol; 1979 Feb; 132(2):309-10. PubMed ID: 105610
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR).
    Hüttel MS; Schou Olesen A; Stoffersen E
    Br J Anaesth; 1980 Jan; 52(1):77-9. PubMed ID: 7378233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to hypersensitivity reactions from intravenous iron preparations.
    Morales Mateluna CA; Scherer Hofmeier K; Bircher AJ
    Allergy; 2017 May; 72(5):827-830. PubMed ID: 27977865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.
    Mészáros T; Csincsi ÁI; Uzonyi B; Hebecker M; Fülöp TG; Erdei A; Szebeni J; Józsi M
    Nanomedicine; 2016 May; 12(4):1023-1031. PubMed ID: 26733258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypersensitivity reactions to intravenous iron: an allergist' perspective].
    Moi L; Stehlin F; Desseauve D; Ribi C; Muller YD
    Rev Med Suisse; 2022 Apr; 18(776):639-645. PubMed ID: 35385614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.
    Moghimi SM; Hunter AC; Dadswell CM; Savay S; Alving CR; Szebeni J
    Biochim Biophys Acta; 2004 Jun; 1689(2):103-13. PubMed ID: 15196591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A red patient: immunological reaction to glycine?
    Moskovits PE; Riches P; Soni N
    Anaesthesia; 1987 Sep; 42(9):962-4. PubMed ID: 3674357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of liposomes with the complement system.
    Szebeni J
    Crit Rev Ther Drug Carrier Syst; 1998; 15(1):57-88. PubMed ID: 9523086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.